Kingworld-Longde Life and Health Industrial Park opens in China

Kingworld Medicines Group has announced that the Group's Kingworld- Longde Life and Health Industrial Park in Bao’an Technology City, Longgang District, Shenzhen, has officially commenced operations.

The opening ceremony, investment promotion conference, and investor tour were successfully held, marking a new chapter in the Group's 30-year journey in the healthcare industry and establishing a national-level pharmaceutical industry incubation and investment base for the Greater Bay Area. On the same day, Kingworld and Foci jointly launched their new product "Foci Kingworld An Gong Niu Huang Wan."

The park features high-standard production facilities and supporting infrastructure, including pharmaceutical waste treatment facilities, backup power supply systems, and centralized pharmaceutical wastewater treatment systems, providing comprehensive support for the diverse needs of resident enterprises.

As a key strategic project of Kingworld Medicines, the Longde Health Industrial Park leverages Kingworld's 30-year global pharmaceutical supply chain resources, mature sales network, and marketing capabilities. It actively integrates pharmaceutical supply chain resources to help park enterprises effectively expand their market channels and provides targeted professional support in financing, listing, policy, and legal matters to accelerate the incubation of pharmaceutical projects and brands aligned with the Group's strategic direction. The Industrial Park has also established innovation platforms, including a Greater Bay Area Youth Exchange Base and Hong Kong Medicine Landing Platform.

Furthermore, the Industrial Park houses high-end research institutions including “Hong Kong Medicine Landing Hub”, “Shenzhen-Hong Kong TCM In-Hospital Preparatory Medicinal Products Center” and “Pharmaceutical GSP Supply Chain Distribution Center”. The park has created a life and health achievement transformation platform integrating research institutions, Shenzhen-Hong Kong medical institutions, research experts, and pharmaceutical distribution, making positive contributions to the innovative development of the biomedical industry in the Greater Bay Area.